{"archive_url":"http://www.ebi.ac.uk/ena/data/view/ERX297453","experiment":{"EXPERIMENT_ID":"ERX297453","EXPERIMENT_TYPE":"Histone H3K27ac","attributes":{"EXTRACTION_PROTOCOL_SONICATION_CYCLES":["3x 10 min; 30 sec ON/ 30 sec OFF"],"CHIP_PROTOCOL_BEAD_TYPE":["magnetic beads A and G"],"CHIP_ANTIBODY":["H3K27ac"],"EXPERIMENT_TYPE":["Histone H3K27ac"],"CHIP_PROTOCOL_BEAD_AMOUNT":["20 µl"],"CHIP_ANTIBODY_CATALOG":["BP grade"],"CHIP_PROTOCOL_ANTIBODY_AMOUNT":["1,0 µg"],"CHIP_ANTIBODY_LOT":["A1723-0041d"],"CHIP_PROTOCOL_CHROMATIN_AMOUNT":["5x 100.000 cells = 5x 6,7 µl"],"EXTRACTION_PROTOCOL":["Chromatin was extracted using the histone protocol. Cells are crosslinked 10 min in 1% formaldehyde. Washed twice in PBS and dissolved in shearing buffer (containing 1% SDS), such that the final concentration is 15*10^6 cells/ml."],"CHIP_PROTOCOL":["Transcription factor protocol: 100.000 cells per ChIP (5x) and pool at the end. Overnight incubation of chromatin with antibody and A/G magnetic beads. Wash twice with buffer 1, once with buffer 2 and 3 and twice with buffer 4 at 4 degrees. Elute 20 min with elution buffer at RT. Descrosslink 4 hours at 65 degrees. Purify by column purification."],"CHIP_ANTIBODY_PROVIDER":["Diagenode"],"EXTRACTION_PROTOCOL_TYPE_OF_SONICATOR":["Bioruptor Plus (UCD-300)"]},"ASSAY_TYPE":"ChIP-Seq"},"archive":"ENA","files":[{"SIZE":"479K","FORMAT":"bigBed","FILE_TYPE":"CS_MACS_TRACK_BB","NAME":"BP_Z-138_c01.H3K27ac.ppqt_macs2_v2.20130819.bb","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh37/Cell_Line/Z-138/Mantle_cell_lymphoma/ChIP-Seq/NCMLS/BP_Z-138_c01.H3K27ac.ppqt_macs2_v2.20130819.bb","PROTOCOL_DOC":"chip_seq","MD5":"538de74b2f8bad7808f51581e846835d"},{"SIZE":"436K","FORMAT":"BED","FILE_TYPE":"CS_MACS2","NAME":"BP_Z-138_c01.H3K27ac.ppqt_macs2_v2.20130819.bed.gz","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh37/Cell_Line/Z-138/Mantle_cell_lymphoma/ChIP-Seq/NCMLS/BP_Z-138_c01.H3K27ac.ppqt_macs2_v2.20130819.bed.gz","PROTOCOL_DOC":"chip_seq","MD5":"9f19a0f346eca0de6445136f25d12297"},{"SIZE":"505K","FORMAT":"Text","FILE_TYPE":"CS_MACS2","NAME":"BP_Z-138_c01.H3K27ac.ppqt_macs2_v2.20130819.xls.gz","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh37/Cell_Line/Z-138/Mantle_cell_lymphoma/ChIP-Seq/NCMLS/BP_Z-138_c01.H3K27ac.ppqt_macs2_v2.20130819.xls.gz","PROTOCOL_DOC":"chip_seq","MD5":"ab1948b02a15386a3d9082cc29f5b370"},{"SIZE":"1.2G","FORMAT":"bigWig","FILE_TYPE":"CS_WIGGLER","NAME":"BP_Z-138_c01.H3K27ac.wiggler.20130819.bw","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Normalized signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh37/Cell_Line/Z-138/Mantle_cell_lymphoma/ChIP-Seq/NCMLS/BP_Z-138_c01.H3K27ac.wiggler.20130819.bw","PROTOCOL_DOC":"chip_seq","MD5":"f32546d457d2f439c423e711bb486d58"}],"ftp_path":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh37/Cell_Line/Z-138/Mantle_cell_lymphoma/ChIP-Seq/NCMLS","sample":{"SAMPLE_SOURCE":"Cell Line","SAMPLE_NAME":"Z-138","sample_barcode":"Z-138_c01","SAMPLE_DESCRIPTION":"Mantle cell lymphoma","SAMPLE_ID":"ERS333896","attributes":{"DIFFERENTIATION_METHOD":["Drexler HG chapter 16 Establishment and culture of leukemia-lymphoma cell in Cancer Cell Culture Methods and Protocols 2nd Edition Springer Berlin pp 181 to 200 in 2011"],"DISEASE":["Mantle cell lymphoma"],"MOLECULE":["genomic DNA"],"LINEAGE":["NA"],"BATCH":["NA"],"BIOMATERIAL_PROVIDER":["WP4_Bergmann_Siebert_Martin-Subero"],"BIOMATERIAL_TYPE":["Cell Line"],"DISEASE_ONTOLOGY_URI":[{"url":"http://ncimeta.nci.nih.gov/ncimbrowser/ConceptReport.jsp?dictionary=NCI%20MetaThesaurus&code=C2853894","label":"C2853894"}],"SAMPLE_ONTOLOGY_URI":[{"url":"http://www.ebi.ac.uk/efo/EFO_0005479","label":"EFO_0005479"}],"SEX":["Male"],"PASSAGE":["NA"],"DIFFERENTIATION_STAGE":["B cell"],"LINE":["Z-138"],"MEDIUM":["RPMI 1640 + 10%FBS"]}}}